Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Chloramphenicol
Drug ID BADD_D00430
Description An antibiotic first isolated from cultures of _Streptomyces venequelae_ in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
Indications and Usage Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.
Marketing Status approved; vet_approved
ATC Code D06AX02; D10AF03; G01AA05; J01BA01; S01AA01; S02AA01; S03AA08
DrugBank ID DB00446
KEGG ID D00104
MeSH ID D002701
PubChem ID 5959
TTD Drug ID D0X6IU
NDC Product Code 62991-1031; 38779-0203; 71052-687; 79572-005; 51552-1419; 51927-0214; 64677-0002; 81918-002; 66478-0155; 59929-783; 53069-0010
UNII 66974FR9Q1
Synonyms Chloramphenicol | Kloramfenikol | Cloranfenicol | Chlornitromycin | Chlorocid | Amphenicol | Amphenicols | Ophthochlor | Syntomycin | Levomycetin | Chloromycetin | Detreomycin
Chemical Information
Molecular Formula C11H12Cl2N2O5
CAS Registry Number 56-75-7
SMILES C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Agranulocytosis01.02.03.001--Not Available
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001--Not Available
Aplastic anaemia01.03.03.002--Not Available
Application site irritation12.07.01.003; 08.02.01.003--Not Available
Application site pain12.07.01.004; 08.02.01.004--Not Available
Blepharitis23.03.04.012; 06.04.04.001--Not Available
Blister12.01.06.002; 23.03.01.001--Not Available
Body temperature increased13.15.01.001--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Chills15.05.03.016; 08.01.09.001--
Circulatory collapse24.06.02.001--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Cyanosis23.06.04.005; 02.11.04.004; 24.03.01.007; 22.02.02.007--
Delirium19.13.02.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Drug interaction08.06.03.001--Not Available
Endophthalmitis11.01.06.003; 06.04.05.009--
Enterocolitis07.08.03.003--
Epistaxis24.07.01.005; 22.04.03.001--
Erythema23.03.06.001--Not Available
Eye disorder06.08.03.001--Not Available
Eye irritation06.04.05.003--Not Available
Eye pain06.08.03.002--
Eye swelling06.08.03.003--Not Available
Feeling abnormal08.01.09.014--Not Available
The 1th Page    1 2 3    Next   Last    Total 3 Pages